Stephens & Co. analyst Vincent Caintic maintains SLM (NASDAQ:SLM) with a Equal-Weight and raises the price target from $16 to $18.
Why Altamira Therapeutics (CYTO) Stock Is Getting Hammered
Altamira Therapeutics Ltd (NASDAQ: CYTO) shares are trading lower by 19.23% to $0.44 Thursday morning after the company announced pricing of a $5 million public offer